360iResearch Logo
Global Human Papillomavirus Vaccine Market
Report Code: MRR-9517C78 | Publishing Date: April 2020 | Number of Pages: 175

Global Human Papillomavirus Vaccine Market | Market Research Report | Cumulative Impact of COVID-19

The Global Human Papillomavirus Vaccine Market to grow from USD xx.xx Million in 2019 to USD xx.xx Million by 2025, at a Compound Annual Growth Rate (CAGR) of xx.xx%. Some of the major market players include Bayer AG, EyeGene Inc., GlaxoSmithKline plc., Inovio Pharmaceuticals Inc., and Johnson & Johnson.

Global Human Papillomavirus Vaccine Market | Market Research Report | Cumulative Impact of COVID-19

Market Dynamics:

The factors attributing to the growth of the market are increasing prevalence of various cancers and stds caused by human papillomavirus and government support & initiatives. However, some factors such as expensive price 0f vaccine and limited clinical trials and acceptability may hinder the market growth. The Human Papillomavirus Vaccine Market is expected to showcase the opportunities such as incentives for vaccine derived from related indications and r&d developments in human papillomavirus vaccines and medication. In the near future market may face the possible challenges in the growth due to concerns over the safety of the hpv vaccine. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Human Papillomavirus Vaccine Market.

Market Segmentation & Coverage:

The research report categorizes the Human Papillomavirus Vaccine Market to forecast the revenues and analyze the trends in each of the following segments:

On the basis of Indication, the Human Papillomavirus Vaccine Market is studied across Anal Cancer, Cervical Cancer, Genital Warts, Oropharyngeal Cancer, Penile Cancer, Vaginal Cancer, and Vulvar Cancer.

On the basis of Valance, the Human Papillomavirus Vaccine Market is studied across Bivalent and Quadrivalent and Nonavalent.

On the basis of Distribution Channel, the Human Papillomavirus Vaccine Market is studied across Government Entities, Physician Distributors, Physicians, Public and Private Alliances, and Wholesalers.

On the basis of Geography, the Human Papillomavirus Vaccine Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The Human Papillomavirus Vaccine Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The Human Papillomavirus Vaccine Market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • Bayer AG
  • EyeGene Inc.
  • GlaxoSmithKline plc.
  • Inovio Pharmaceuticals Inc.
  • Johnson & Johnson
  • Mayo Clinic
  • Merck & Co., Inc.
  • Merck Sharp & Dohme Corp
  • Nuron Biotech Inc.
  • Pfizer Inc.
  • Planned Parenthood Federation of America Inc.
  • Sanofi S.A.

Scope of the Report:

AttributeDetails
Base Year for Estimation2019
Historical Period2017 - 2018
Estimation Period2020 - 2021
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Human Papillomavirus Vaccine Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Human Papillomavirus Vaccine Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Human Papillomavirus Vaccine Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Human Papillomavirus Vaccine Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Human Papillomavirus Vaccine Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Human Papillomavirus Vaccine Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Human Papillomavirus Vaccine Market .
  • Evaluate the key vendors in the Human Papillomavirus Vaccine Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
    2. Forecasting Methodology
  3. Executive Summary
    1. Market Outlook
    2. Geography Outlook
    3. Competitor Outlook
  4. Market Overview
    1. Introduction
    2. Human Papillomavirus Vaccine Market, By Geography
    3. Human Papillomavirus Vaccine Market, By Indication
    4. Human Papillomavirus Vaccine Market, By Valance
    5. Human Papillomavirus Vaccine Market, By Distribution Channel
  5. Market Dynamics
    1. Introduction
    2. Drivers
      1. Increasing prevalence of various cancers and STDs caused by human papillomavirus
      2. Government support & initiatives
    3. Restraints
      1. Expensive price 0f vaccine
      2. Limited clinical trials and acceptability
    4. Opportunities
      1. Incentives for vaccine derived from related indications
      2. R&D developments in human papillomavirus vaccines and medication
    5. Challenges
      1. Concerns over the safety of the HPV vaccine
  6. Industry Trends
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
      1. Clinical Trials & Trends
      2. Pricing Analysis & Trend
  7. Human Papillomavirus Vaccine Market, By Indication
    1. Introduction
    2. Anal Cancer
    3. Cervical Cancer
    4. Genital Warts
    5. Oropharyngeal Cancer
    6. Penile Cancer
    7. Vaginal Cancer
    8. Vulvar Cancer
  8. Human Papillomavirus Vaccine Market, By Valance
    1. Introduction
    2. Bivalent
    3. Quadrivalent and Nonavalent
  9. Human Papillomavirus Vaccine Market, By Distribution Channel
    1. Introduction
    2. Government Entities
    3. Physician Distributors
    4. Physicians
    5. Public and Private Alliances
    6. Wholesalers
  10. Human Papillomavirus Vaccine Market, By Americas
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  11. Human Papillomavirus Vaccine Market, By Asia-Pacific
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  12. Human Papillomavirus Vaccine Market, By Europe, Middle East & Africa
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  13. Competitive Landscape
    1. FPNV Positioning Matrix
    2. Market Vendor Ranking Analysis
    3. Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
  14. Company Usability Profiles
    1. Bayer AG
    2. EyeGene Inc.
    3. GlaxoSmithKline plc.
    4. Inovio Pharmaceuticals Inc.
    5. Johnson & Johnson
    6. Mayo Clinic
    7. Merck & Co., Inc.
    8. Merck Sharp & Dohme Corp
    9. Nuron Biotech Inc.
    10. Pfizer Inc.
    11. Planned Parenthood Federation of America Inc.
    12. Sanofi S.A.
  15. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: SEGMENTATION & COVERAGE
  2. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, 2017-2025 (USD MILLION)
  3. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  4. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY ANAL CANCER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY CERVICAL CANCER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY GENITAL WARTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  7. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY OROPHARYNGEAL CANCER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY PENILE CANCER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VAGINAL CANCER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VULVAR CANCER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  11. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  12. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY BIVALENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY QUADRIVALENT AND NONAVALENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  14. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  15. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY GOVERNMENT ENTITIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  16. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  17. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY PHYSICIANS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY PUBLIC AND PRIVATE ALLIANCES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  19. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY WHOLESALERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  20. AMERICAS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLION)
  21. AMERICAS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  22. AMERICAS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  23. AMERICAS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  24. ARGENTINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  25. ARGENTINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  26. ARGENTINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  27. BRAZIL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  28. BRAZIL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  29. BRAZIL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  30. CANADA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  31. CANADA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  32. CANADA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  33. MEXICO HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  34. MEXICO HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  35. MEXICO HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  36. UNITED STATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  37. UNITED STATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  38. UNITED STATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  39. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLION)
  40. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  41. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  42. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  43. AUSTRALIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  44. AUSTRALIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  45. AUSTRALIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  46. CHINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  47. CHINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  48. CHINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  49. INDIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  50. INDIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  51. INDIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  52. INDONESIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  53. INDONESIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  54. INDONESIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  55. JAPAN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  56. JAPAN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  57. JAPAN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  58. MALAYSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  59. MALAYSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  60. MALAYSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  61. PHILIPPINES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  62. PHILIPPINES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  63. PHILIPPINES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  64. SOUTH KOREA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  65. SOUTH KOREA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  66. SOUTH KOREA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  67. THAILAND HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  68. THAILAND HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  69. THAILAND HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  70. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLION)
  71. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  72. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  73. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  74. FRANCE HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  75. FRANCE HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  76. FRANCE HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  77. GERMANY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  78. GERMANY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  79. GERMANY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  80. ITALY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  81. ITALY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  82. ITALY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  83. NETHERLANDS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  84. NETHERLANDS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  85. NETHERLANDS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  86. QATAR HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  87. QATAR HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  88. QATAR HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  89. RUSSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  90. RUSSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  91. RUSSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  92. SAUDI ARABIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  93. SAUDI ARABIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  94. SAUDI ARABIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  95. SOUTH AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  96. SOUTH AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  97. SOUTH AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  98. SPAIN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  99. SPAIN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  100. SPAIN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  101. UNITED ARAB EMIRATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  102. UNITED ARAB EMIRATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  103. UNITED ARAB EMIRATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  104. UNITED KINGDOM HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  105. UNITED KINGDOM HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2017-2025 (USD MILLION)
  106. UNITED KINGDOM HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  107. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: RANKING
  108. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: BUSINESS STRATEGY
  109. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: PRODUCT SATISFACTION
  110. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: MERGER & ACQUISITION
  111. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: AGREEMENT, COLLABORATION & PARTNERSHIP
  112. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  113. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: INVESTMENT & FUNDING
  114. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: EDITION DETAILS
  115. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: LICENSE DETAILS
  116. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: RESEARCH PROCESS
  2. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: RESEARCH FRAMEWORK
  3. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: FORECASTING METHODOLOGY
  4. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  5. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY TYPE
  6. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, 2017-2025 (USD MILLION)
  7. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  8. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  9. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2019 VS 2025 (USD MILLION)
  10. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
  11. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: MARKET DYNAMICS
  12. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
  13. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: CUMULATIVE IMPACT OF COVID-19
  14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2025 (USD MILLION)
  15. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY ANAL CANCER SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  16. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY CERVICAL CANCER SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  17. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY GENITAL WARTS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  18. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY OROPHARYNGEAL CANCER SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  19. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY PENILE CANCER SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  20. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY VAGINAL CANCER SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  21. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY VULVAR CANCER SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2025 (USD MILLION)
  23. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY BIVALENT SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  24. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY QUADRIVALENT AND NONAVALENT SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 (USD MILLION)
  26. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY GOVERNMENT ENTITIES SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  27. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY PHYSICIAN DISTRIBUTORS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  28. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY PHYSICIANS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  29. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY PUBLIC AND PRIVATE ALLIANCES SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  30. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY WHOLESALERS SIZE, BY GEOGRAPHY, 2019 (USD MILLION)
  31. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: FPNV POSITIONING MATRIX
  1. Bayer AG
  2. EyeGene Inc.
  3. GlaxoSmithKline plc.
  4. Inovio Pharmaceuticals Inc.
  5. Johnson & Johnson
  6. Mayo Clinic
  7. Merck & Co., Inc.
  8. Merck Sharp & Dohme Corp
  9. Nuron Biotech Inc.
  10. Pfizer Inc.
  11. Planned Parenthood Federation of America Inc.
  12. Sanofi S.A.
Global Human Papillomavirus Vaccine Market
Report Code
MRR-9517C78
Publishing Date
April 2020
Number of Pages
175
Available Formats

SELECT LICENSE TYPE

ENTERPRISE USER LICENSE $7949
CORPORATE USER LICENSE $6449
SINGLE USER LICENSE $4949